Application Sponsors
| ANDA 213266 | AUROBINDO PHARMA LTD | |
Marketing Status
| Over-the-counter | 001 |
| Over-the-counter | 002 |
Application Products
| 001 | TROCHE/LOZENGE;ORAL | EQ 2MG BASE | 0 | NICOTINE POLACRILEX | NICOTINE POLACRILEX |
| 002 | TROCHE/LOZENGE;ORAL | EQ 4MG BASE | 0 | NICOTINE POLACRILEX | NICOTINE POLACRILEX |
FDA Submissions
| UNKNOWN; | ORIG | 1 | AP | 2021-08-03 | STANDARD |
Submissions Property Types
CDER Filings
AUROBINDO PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 213266
[companyName] => AUROBINDO PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"NICOTINE POLACRILEX","activeIngredients":"NICOTINE POLACRILEX","strength":"EQ 2MG BASE","dosageForm":"TROCHE\/LOZENGE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"},{"drugName":"NICOTINE POLACRILEX","activeIngredients":"NICOTINE POLACRILEX","strength":"EQ 4MG BASE","dosageForm":"TROCHE\/LOZENGE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/03\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-08-03
)
)